Groowe Groowe / Newsroom / IBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IBIO News

iBio, Inc. Common Stock

Form 8-K

sec.gov
IBIO

iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update

globenewswire.com
IBIO

Form 8-K

sec.gov
IBIO

iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors

globenewswire.com
IBIO

Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight

globenewswire.com
ADAG ABBV BIIB BMRN BLRX CNSP CYCN GEN GILD GRAF GSK HSIC HUBS IBIO INCY JAZZ JNJ MAGN MARA MRK NVS OMER PFE PRGS REGN RGNX SRPT TENB TGLS TGTX TNDM TXG VRTX

Form 8-K/A

sec.gov
IBIO

Form 8-K

sec.gov
IBIO

iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia

globenewswire.com
IBIO

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

globenewswire.com
IBO IBIO

Lab-Grown Neurons Say "Hello, World!" and Perform Matrix Math on Automated Platform; Intactis Bio Corp Raises $250K from Nucleus Fund

prnewswire.com
IBIO